copyright, a relatively novel medication, has emerged as a potential landmark achievement in the management of type 2 diabetes. This injectable drug affects the incretin hormones GLP-1, which play a vital role in regulating glucose regulation. By mimicking these hormones, copyright helps decrease glycemic values, potentially leading to improved reg